title: Total-body irradiation and cataract incidence: a randomized comparison of two instantaneous dose rates.
abstract: OBJECTIVE
  To assess the influence of instantaneous total-body irradiation dose rate in hematological malignancies, we randomized 157 patients according to different instantaneous dose rates.
  
  
  METHODS
  Between December 10, 1986 and December 31, 1989 157 patients have undergone a total-body irradiation before bone-marrow transplantation according to two different techniques: either in one fraction (1000 cGy given to the midplane at the level of L4, and 800 cGy to the lungs) or in six fractions (1200 cGy over 3 consecutive days to the midplane at the level of L4, and 900 cGy to the lungs). Patients were randomized according to two instantaneous dose rates, called LOW and HIGH, in single-dose (6 vs. 15 cGy/min) and fractionated (3 vs. 6 cGy/min) TBI groups; there were 77 cases for the LOW and 80 for the HIGH groups, with 57 patients receiving single-dose (28 LOW, 29 HIGH) and 100 patients receiving fractionated total-body irradiation (49 LOW, 51 HIGH).
  
  
  RESULTS
  As of July 1992, 16 (10%) of 157 patients developed cataracts after 17 to 46 months, with an estimated incidence of 23% at 5 years. Four (5%) of 77 patients in the LOW group, 12 (15%) of 80 patients in the HIGH group developed cataracts, with 5-year estimated incidences of 12% and 34%, respectively (p = 0.03). Ten (18%) of 57 patients in the single-dose group, and 6 (6%) of 100 patients in the fractionated group developed cataracts, with 5-year estimated incidences of 39% and 13%, respectively (p = 0.02). When the subgroups were considered, in the single-dose group, 3 (11%) of 28 LOW patients, and 7 (24%) of 29 HIGH patients developed cataracts, with 5-year estimated incidences of 24% and 53%, respectively; in the fractionated group, 1 (2%) of 49 LOW patients, and 5 (10%) of 51 HIGH patients developed cataracts, with 5-year estimated incidences of 4% and 22%, respectively (single-dose LOW vs. single-dose HIGH vs. fractionated LOW vs. fractionated HIGH, p = 0.006). There was no statistically significant difference in terms of 5-year estimated cataract incidence between the patients receiving steroids and those not (30% vs. 25%, p = 0.22). Multivariate analyses revealed that the instantaneous dose rate was the only independent factor influencing the cataractogenesis (p = 0.04).
  
  
  CONCLUSIONS
  We conclude that the total-body irradiation regimen (instantaneous dose rate and/or fractionation) may have an influence on the development of cataracts following bone-marrow transplantation.
authors.affiliation: Services de Radiothérapie A et B, Hôpital Tenon, Paris, France.
authors.forename: M
authors.initials: M
authors.lastname: Ozsahin
authors.forename: Y
authors.initials: Y
authors.lastname: Belkacemi
authors.forename: F
authors.initials: F
authors.lastname: Pene
authors.forename: C
authors.initials: C
authors.lastname: Dominique
authors.forename: L H
authors.initials: LH
authors.lastname: Schwartz
authors.forename: C
authors.initials: C
authors.lastname: Uzal
authors.forename: D
authors.initials: D
authors.lastname: Lefkopoulos
authors.forename: B
authors.initials: B
authors.lastname: Gindrey-Vie
authors.forename: L
authors.initials: L
authors.lastname: Vitu-Loas
authors.forename: E
authors.initials: E
authors.lastname: Touboul
mesh_terms: D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000009:adverse effects; D000328:Adult; D016026:Bone Marrow Transplantation; D002386:Cataract / Q000209:etiology*; D002648:Child; D004307:Dose-Response Relationship, Radiation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011879:Radiotherapy Dosage; D014916:Whole-Body Irradiation / Q000009:adverse effects*
chemical_list: D000305:Adrenal Cortex Hormones